Condition: Wilms Tumor · Rhabdoid Tumor · Malignant Peripheral Nerve Sheath Tumors · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to find out whether selinexor is an effective treatment for people who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNST, BCOR-driven sarcoma, or another solid tumor that makes a higher than normal amount of XPO1 or has genetic changes that increase the activity of XP01.
This description comes directly from the study's public registry record.
Michael Ortiz, MD · 1-833-MSK-KIDS · ortizm2@mskcc.org
Julia Glade Bender, MD · 1-833-MSK-KIDS
Always discuss trial participation with your own doctor first.
| Children's Hospital of Los Angeles (Data Collection Only) | Los Angeles, California, United States | Recruiting |
| Stanford Medicine Children's Health (Data Collection Only) | Palo Alto, California, United States | Recruiting |
| Children's National Hospital (Data Collection Only) | Washington D.C., District of Columbia, United States | Recruiting |
| Children's Healthcare of Atlanta (Data Collection and Specimen Analysis) | Atlanta, Georgia, United States | Recruiting |
| Ann & Robert H. Lurie Children'S Hospital of Chicag | Chicago, Illinois, United States | Recruiting |
| Dana Farber Cancer Institute (Data Collection Only) | Boston, Massachusetts, United States | Recruiting |
| Washington University | St Louis, Missouri, United States | Recruiting |
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (Limited protocol activities) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison, New York, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05985161